| An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging S Drabycz, G Roldán, P De Robles, D Adler, JB McIntyre, AM Magliocco, ... Neuroimage 49 (2), 1398-1405, 2010 | 237 | 2010 |
| POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium B Meng, LN Hoang, JB McIntyre, MA Duggan, GS Nelson, CH Lee, ... Gynecologic oncology 134 (1), 15-19, 2014 | 206 | 2014 |
| Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme AE Sijben, JB McIntyre, GB Roldán, JC Easaw, E Yan, PA Forsyth, ... Journal of neuro-oncology 89, 97-103, 2008 | 164 | 2008 |
| PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy JB McIntyre, JS Wu, PS Craighead, T Phan, M Köbel, SP Lees-Miller, ... Gynecologic oncology 128 (3), 409-414, 2013 | 133 | 2013 |
| A somatic activating NRAS variant associated with kaposiform lymphangiomatosis SF Barclay, KW Inman, VL Luks, JB McIntyre, A Al-Ibraheemi, AJ Church, ... Genetics in Medicine 21 (7), 1517-1524, 2019 | 112 | 2019 |
| Targeted mutation analysis of endometrial clear cell carcinoma LN Hoang, MK McConechy, B Meng, JB McIntyre, C Ewanowich, CB Gilks, ... Histopathology 66 (5), 664-674, 2015 | 110 | 2015 |
| Morphologic reproducibility, genotyping, and immunohistochemical profiling do not support a category of seromucinous carcinoma of the ovary PF Rambau, JB McIntyre, J Taylor, S Lee, T Ogilvie, A Sienko, D Morris, ... The American Journal of Surgical Pathology 41 (5), 685-695, 2017 | 84 | 2017 |
| Population-based study of pseudoprogression after chemoradiotherapy in GBM GB Roldán, JN Scott, JB McIntyre, M Dharmawardene, PA De Robles, ... Canadian Journal of Neurological Sciences 36 (5), 617-622, 2009 | 74 | 2009 |
| The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors AD Altman, GS Nelson, P Ghatage, JB McIntyre, D Capper, P Chu, ... Modern Pathology 26 (9), 1255-1263, 2013 | 72 | 2013 |
| Determination of the methylation status of MGMT in different regions within glioblastoma multiforme MG Hamilton, G Roldán, A Magliocco, JB McIntyre, I Parney, JC Easaw Journal of neuro-oncology 102, 255-260, 2011 | 61 | 2011 |
| Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells W Arjumand, CD Merry, C Wang, E Saba, JB McIntyre, S Fang, E Kornaga, ... Oncotarget 7 (50), 82424, 2016 | 42 | 2016 |
| Methylation status of MGMT gene promoter in meningiomas P De Robles, J McIntyre, S Kalra, G Roldán, G Cairncross, P Forsyth, ... Cancer genetics and cytogenetics 187 (1), 25-27, 2008 | 38 | 2008 |
| Molecular alterations in indolent, aggressive and recurrent ovarian low‐grade serous carcinoma JB McIntyre, PF Rambau, A Chan, S Yap, D Morris, GS Nelson, M Köbel Histopathology 70 (3), 347-358, 2017 | 36 | 2017 |
| PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma JB McIntyre, GS Nelson, P Ghatage, D Morris, MA Duggan, CH Lee, ... Gynecologic Oncology 132 (1), 188-193, 2014 | 26 | 2014 |
| Specific and sensitive hydrolysis probe-based real-time PCR detection of epidermal growth factor receptor variant III in oral squamous cell carcinoma JB McIntyre, P Bose, AC Klimowicz, NT Brockton, S Petrillo, W Matthews, ... PLoS One 7 (2), e31723, 2012 | 20 | 2012 |
